BiotechTube

Cefiderocol

ApprovedRecruiting
0 watching 0 views this week🔥 Hot
85
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Drug Clearance After Severe Burn Injury

Conditions

Drug Clearance After Severe Burn Injury

Trial Timeline

Feb 16, 2026 → Feb 28, 2027

NCT ID
NCT07465432

About Cefiderocol

Cefiderocol is a approved stage product being developed by Shionogi for Drug Clearance After Severe Burn Injury. The current trial status is recruiting. This product is registered under clinical trial identifier NCT07465432. Target conditions include Drug Clearance After Severe Burn Injury.

Hype Score Breakdown

Clinical
30
Activity
20
Company
10
Novelty
10
Community
12

Clinical Trials (7)

NCT IDPhaseStatus
NCT03780140Pre-clinicalCompleted
NCT07465432ApprovedRecruiting
NCT05789199Pre-clinicalCompleted
NCT05373615Phase 1Completed
NCT05314764ApprovedCompleted
NCT04995835Phase 1Completed
NCT03869437Phase 2Completed

Competing Products

20 competing products in Drug Clearance After Severe Burn Injury

See all competitors
ProductCompanyStageHype Score
ORIN1001Fosun PharmaPhase 1/2
40
GP404141 + NplateGEROPHARMPhase 3
69
Crestor 10mg(Rosuvastatin 10mg), Glucodown OR SR 750mg(Metformin SR 750mg)YuhanPhase 1
33
Tolbutamide + Midazolam + PexidartinibDaiichi SankyoPhase 1
33
DS-8500a + RosuvastatinDaiichi SankyoPhase 1
33
DS-1040b + ClopidogrelDaiichi SankyoPhase 1
33
EC905 + verapamilAstellas PharmaPhase 1
33
rosuvastatin + fidaxomicinAstellas PharmaPhase 1
33
enzalutamide + rifampinAstellas PharmaPhase 1
33
ASP3652 + Gemfibrozil + RepaglinideAstellas PharmaPhase 1
33
Placebo + Active Comparator #1 + Active Comparator #2 + Active Comparator #3 + Lorcaserin Dose #1 + Lorcaserin Dose #2 + Lorcaserin Dose #3EisaiPhase 1
33
Istradefylline + Phentermine 45 mgKyowa KirinPhase 1
33
Lasmiditan + Alprazolam + PlaceboEli LillyPhase 1
33
Nasal Glucagon (NG) + Glucagon IMEli LillyPhase 3
77
napabucasin + cytochrome P450 (CYP450) probe drugs or BCRP transporter substrateSumitomo PharmaPhase 1
33
Norgestimate; Ethinyl Estradiol; Folic acidJohnson & JohnsonPhase 1
33
Norgestimate; Ethinyl Estradiol; Folic acidJohnson & JohnsonPhase 1
33
Loperamide / Red Grapefruit Juice + Loperamide/ White Grapefruit Juice + Loperamide / Pink Grapefruit JuiceJohnson & JohnsonPhase 1
33
HR17031 injection + insulin glargineJiangsu Hengrui MedicinePhase 3
77
Pyrotinib Maleate + EfavirenzJiangsu Hengrui MedicinePhase 1
33

Other Products from Shionogi

Naldemedine + PlaceboApproved
85
Rosuvastatin + HMG CoA inhibitorApproved
85
StatinApproved
85
CefiderocolApproved
85
Duloxetine + Pregabalin + PlaceboApproved
85